1[1]van Meerbeeck JP. Staging of non-small cell lung cancer: consensus, controversies and challenges[J]. Lung Cancer,2001,34(suppl 1):S95-S107. 被引量：1
2[2]Patz EF, Rossi S, Harpole DH, et al. Correlation of tumor size and survival in patients with stageⅠa non-small cell lung cancer[J]. Chest,2000,117(6):1568-1571. 被引量：1
3[3]Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery. Clinical tumour size and prognosis in lung cancer[J]. Eur Respir J,1999,14(4):812-816. 被引量：1
4[4]Leong SS, Rocha Lima CM, Sherman CA, et al. The 1977 international staging system for non-small cell lung cancer. Have all the issues been addressed? [J] Chest,1999,115(1):242-248. 被引量：1
5[5]Urschel JD, Urschel DM, Anderson M, et al. Prognostic implications of pulmonary satellite nodules: are the 1977 staging revisions appropriate? [J] Lung Cancer, 1998,21(2):83-87. 被引量：1
6[6]Machtay M, Seiferheld W, Komaki R, et al. Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy? Analysis of the Radiation Therapy Oncology Group experience[J]. Int J Radiat Oncol Biol Phys, 1999,44(4):847-853. 被引量：1
7[7]Patz EF Jr, Connolly J, Herndon J, Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer[J]. AJR Am J Roentgenol ,2000,174(3):769-774. 被引量：1
8[8]Wu YL,Huang ZF, WangSY, et al.A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer[J]. Lung Cancer,2002,36(1):1-6. 被引量：1
